Jonathan Jarvina, MD
Hospitalist · Mesa, AZNPI 1609105204
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $682 of the $760 with a category attached, or 89.7%. 10 manufacturers reported payments, led by Novo Nordisk at 30.7% of the total. Reporting peaked in 2023 at $226 and has fallen 79.7% since, to $46 in 2024. Among hospitalist clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $33.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$234
- Abbott$196
- Inari Medical, Inc.$132
- Amgen$58
- Johnson & Johnson$45
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$31
- plus $66 from 4 others
What the payments were for
- Food & beverage$68290%
- Education$7910%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 7 | $234 |
| Abbott | 4 | $196 |
| Inari Medical, Inc. | 1 | $132 |
| Amgen | 3 | $58 |
| Johnson & Johnson | 2 | $45 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $31 |
| Boehringer Ingelheim | 2 | $30 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Novartis | 1 | $13 |
| Hologic Sales And Service, LLC | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$760 in reported general payments places this provider in the 90th percentile of 578 hospitalist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BriviactBrivaracetam | 12 | $17,564 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $3,031 |
| Liothyronine Sodium | 11 | $454 |
| Levothyroxine Sodium | 28 | $365 |
| Tamsulosin Hcl | 21 | $335 |
| Metformin Hcl | 18 | $234 |
| Losartan Potassium | 11 | $111 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Mesa
- Madiha SajjadMesa$3K
- Mashood SajjadMesa$3K
- Dheeraj BobbaMesa$2K
- Mohd JibreelMesa$2K
- Mark PostacchiniMesa$1K
- Izabela PostacchiniMesa$1K
- Paramvir SinghMesa$1K
- Sachin MehtaScottsdale$10K
- Holly GeyerScottsdale$8K
- Aldine ChandlerTucson$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.